The use of intravenous buprenorphine for the treatment of opioid withdrawal in medically ill hospitalized patients

Christopher J. Welsh, Meenakshi Suman, Art Cohen, Lauren Broyles, Melanie Bennett, Eric Weintraub

Research output: Contribution to journalArticlepeer-review

Abstract

The aim of this study was to assess the safety of buprenorphine administered intravenously for the treatment of opioid withdrawal in medically ill hospitalized patients. Data regarding, demographic information, number of doses of buprenorphine, and measures of buprenorphine's effects were collected via chart reviews for 30 heroin-patients who received buprenorphine intravenously during their hospitalization for an acute medical problem. No respiratory depression was observed, and no patients reported feeling "high." All patients reported that buprenorphine decreased withdrawal symtoms. Thus, intravenous administration of buprenorphine appears to be safe for the treatment of opioid withdrawal.

Original languageEnglish (US)
Pages (from-to)135-140
Number of pages6
JournalAmerican Journal on Addictions
Volume11
Issue number2
DOIs
StatePublished - Jun 1 2002

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Clinical Psychology
  • Psychiatry and Mental health

Fingerprint Dive into the research topics of 'The use of intravenous buprenorphine for the treatment of opioid withdrawal in medically ill hospitalized patients'. Together they form a unique fingerprint.

Cite this